Aino Fianu-Jonasson Selected Research

NASHA-Dx copolymer

8/2004

Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aino Fianu-Jonasson Research Topics

Disease

2	Overactive Urinary Bladder (Overactive Bladder) 06/2017 - 01/2016
2	Stress Urinary Incontinence 01/2006 - 08/2004
1	Trisomy (Trisomies) 10/2019
1	Aneuploidy (Aneuploid) 01/2018
1	Urinary Retention 06/2017
1	Menorrhagia 09/2005
1	Cough 08/2004

Drug/Important Bio-Agent (IBA)

2	Cell-Free Nucleic AcidsIBA 10/2019 - 01/2018
2	Solifenacin Succinate FDA Link 06/2017 - 01/2016
2	mirabegronIBA 06/2017 - 01/2016
2	Hyaluronic Acid (Hyaluronan)IBA 01/2006 - 08/2004
2	dextranomerIBA 01/2006 - 08/2004
1	DNA (Deoxyribonucleic Acid)IBA 10/2019
1	dichlorobis(azomycin)platinum IIIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2005
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 09/2005
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2005
1	NASHA-Dx copolymerIBA 08/2004

Therapy/Procedure

1	Aftercare (After-Treatment) 08/2004
1	Therapeutics 08/2004